In response to international safety alerts, health authorities in Vietnam have requested specialized institutes to establish uniform testing standards for... Read more
Category: Uncategorized
The hidden value of routine interactions in management
Recent research (forthcoming in the Journal of Personality and Social Psychology) suggests that senior leaders systematically miscalculate the value of... Read more
Roche invests $480M in South Korea to build global clinical trial ‘ecosystem’
Swiss pharmaceutical giant Roche is injecting 710 billion won (approximately $484 million) into South Korea’s biopharma sector. This investment aims... Read more
Fujifilm unveils ShunzymeX: A breakthrough in complex biologics purification
On March 4, 2026, Fujifilm Biotechnologies introduced ShunzymeX, a precision purification technology designed to streamline downstream processing for complex biologics.... Read more
Moderna to pay up to $2.25B to resolve mRNA vaccine patent dispute
In a last-minute breakthrough just days before a scheduled jury trial, Moderna has agreed to a settlement worth up to... Read more
Teva and Blackstone Life Sciences strike $400M deal to advance duvakitug
On March 3, 2026, Teva Pharmaceuticals and Blackstone Life Sciences announced a $400 million strategic funding agreement to accelerate the... Read more
Antengene and UCB strike $1.18B global license deal for bispecific T-cell engager
On March 4, 2026, Antengene Corporation and UCB entered into a global licensing agreement worth up to $1.18 billion to... Read more
Sanofi secures $1.5B global license for Sino Biopharm’s first-in-class JAK/ROCK asset
Sanofi has entered into a significant $1.53 billion global licensing agreement with Sino Biopharmaceutical for rovadicitinib, a first-in-class dual JAK/ROCK... Read more
Moderna settles years-long COVID-19 patent feud with $950M payment
Moderna has resolved a protracted legal battle by agreeing to a $950 million upfront settlement with Genevant and Arbutus Biopharma.... Read more









